Michael Edelstein - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Michael Edelstein's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Michael Edelstein
Verified
Host, Accountants EXPOSED (Podcast)
New South Wales
Beats
literature, entertainment and arts current affair, news business and finances, sports foreign policy,politics
Politics,
Content
By Samantha L. Ginn, Mawj Mandwie, Ian Alexander, Michael Edelstein| Wiley Online Library Verified CONFLICT OF INTEREST STATEMENT ME and MRA receive payment from John Wiley and Sons Ltd for their work on The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide database. SLG, MM and IEA declare that they have no conflicts of interest. REFERENCES 1 The U.S. Food and Drug Administration. Press Announcement 2017. FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss.
By Adi Sharabi-Nov, Michael Edelstein, Ekaterina Pundyk Babitzki, Raed Farhat| preprints.org@ Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 21 December 2023 / Approved: 22 December 2023 / Online: 22 December 2023 (14:27:34 CET) Sharabi-Nov, A.; Pundyk Babitzki, E.; Farhat, R.; Edelstein, M.; Avraham, Y.; Merchavy, S. Goiter Prevalence among Druze population in Northern Israel. Preprints 2023, 2023121721. https://doi.org/10.20944/preprints202312.1721.v1 Sharabi-Nov, A.; Pundyk Babitzki, E.; Farhat, R.; Edelstein, M.; Avraham, Y.; Merchavy, S.
By Samantha L. Ginn, Mawj Mandwie, Ian Alexander, Michael Edelstein| Wiley Online Library Verified CONFLICT OF INTEREST STATEMENT ME and MRA receive payment from John Wiley and Sons Ltd for their work on The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide database. SLG, MM and IEA declare that they have no conflicts of interest. REFERENCES 1 The U.S. Food and Drug Administration. Press Announcement 2017. FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss.
Company Info
Accountants EXPOSED (Podcast)
New South Wales, Australia